Overview

Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
To study the cost utility analysis of Erythropoietin (EPO) for maintaining the different hemoglobin (Hb) target levels in anemic hemodialysis patient in routine clinical practice.
Details
Lead Sponsor:
Mahidol University
Treatments:
Epoetin Alfa